Booster doses of COVID-19 vaccine enhance neutralization efficiency against XBB.1.5

Affiliations

¹ Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montréal, Québec, Canada.
² Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada; Health Technology Assessment Unit, McGill University Health Center, Montréal, Québec, Canada.
³ Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
⁴ Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada; Center for Outcomes Research and Evaluation, Research Institute of the McGill University Health Center, Montréal, Québec, Canada.
⁵ Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montréal, Québec, Canada; Department of Pediatrics, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada. Electronic address: bruce.mazer@mcgill.ca.

Elsa Sakr et al. J Allergy Clin Immunol. 2024 Mar.

. 2024 Mar;153(3):874-875.

doi: 10.1016/j.jaci.2023.11.912. Epub 2023 Dec 27.

¹ Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montréal, Québec, Canada.
² Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada; Health Technology Assessment Unit, McGill University Health Center, Montréal, Québec, Canada.
³ Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
⁴ Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada; Center for Outcomes Research and Evaluation, Research Institute of the McGill University Health Center, Montréal, Québec, Canada.
⁵ Translational Research in Respiratory Diseases, Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montréal, Québec, Canada; Department of Pediatrics, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada. Electronic address: bruce.mazer@mcgill.ca.

No abstract available

References